Insider Trades: 23 ASX 200 directors bought and sold these stocks last week

Welcome back to the Insider Trades series – a weekly summary of on-market ASX 200 director transactions valued at more than $10,000. The below trades have all taken place between 31 August and 3 September. Directors have up to 5 business days to notify the ASX of their trades.

With reporting season finished and the blackout windows fully cleared, there’s still a considerable amount of director transactions to unpack even though the herd has thinned a little from last week. Three stocks account for nine of the week's buys, and in two of those the directors are buying into the dip rather than out of it.

Ansell insiders buy into strength

Non executive directors Jonas Samuelson and Debra Goodin both bought on 31 August, a week after Ansell delivered its FY26 result on 24 August and the shares rallied 9% on the day. It was Samuelson’s first purchase since joining the company in March.

Key numbers from the result compared to consensus and Morgans estimates:

• Sales up 6.8% to $2,140.2m vs $2,067m ests (3.5% beat)

• Adjusted EBIT up 14.1% to $321.9m vs $314m ests (2.5% beat)

• Adjusted NPAT up 15.8% to $212.3m vs $202.9m Morgans (4.6% beat)

• Full year DPS up 35.7% to US68.1 cents vs US62.9 cents Morgans (8.3% beat)

• FY27 adjusted EPS guidance of US 158-170 cents, midpoint 164 cents vs 147.7 cents ests (11.0% above)

Ansell’s shares are up a further 10% since posting its results on August 24.

IPH directors keep buying the dip

IPH’s shares tumbled 11% after reporting its earnings on 20 August and directors have been buying the dip since blackout windows lifted, this being the second consecutive week of insider trades. It is also new CEO Anthony O'Malley’s first transaction in the stock since joining the company at the beginning of July. 

Source: Market index

Key numbers from FY26 result against consensus:

• Revenue up 0.4% to $712.8m vs $728.2m ests (2.1% miss),

• Underlying EBITDA down 0.6% to $205.9m vs $212.8m ests (3.2% miss)

• Underlying NPATA up 1.7% to $122.7m vs $123.1m ests (0.3% miss)

• Total FY26 dividends up 5.5% to 38.5cps vs 37.7cps ests (2.1% beat), final dividend 19.5cps at 30% franked and flat on pcp

There was some modest underlying growth in FY26 when looking deeper at the numbers, with Canada the standout, but ultimately soft filing activity and currency weighed on the group. Macquarie retained its Neutral rating after the result, with Canada the highlight on like-for-like underlying EBITDA up 11.8%, while ANZ fell 7.2% on declining US PCT applications and Asia slipped 1.3% on cost inflation. Corporate cost savings and capital management supported the result, though Macquarie wants an improved filing activity outlook before turning more positive.

Shares in Ansell have dropped a further 5.7% since the result.

Four Pexa directors buy the dip

Pexa reported on 28 August and the shares fell 17.4% on the day, closing within a few cents of their 52-week low. Three directors bought on the next trading day and a fourth followed on 1 September, paying between $6.87 and $7.28 per share.

Source: Market index

The result itself was solid, it was the outlook that did the damage. Here are the results against Macquarie’s forecasts:

• Group revenue up 7% to $406.9m vs $414.8m ests (1.9% miss)

• Group EBITDA up 12% to $151.7m vs $147.0m ests (3.2% beat)

  • Australia revenue up 8% to $345.6m vs $344.6m ests (in line)

  • International revenue up 1% to $61.3m vs $70.2m ests (12.7% miss)

• FY27 revenue guidance of $385-415m sits 6.7% below ests at the midpoint, with management flagging that Australian transfer volumes softened in July 2026

• FY27 EBITDA margin guidance of 31.5-33.5% implies roughly $130m at the midpoint, 10.2% below ests and a step down of about 500bps from FY26

The company expects a double-digit decline in Australian property transfer volumes in FY27, and the state pricing regulator has proposed a 20% cut to regulated revenues. 

Other ASX 200 insider buys

Source: Market index

Top ASX 200 insider sells

There was only one sell of consequence, and it was a big one.

Genesis Minerals Executive Chair Raleigh Finlayson sold five million shares on 2 September through MSH Group Pty Ltd, the Finlayson family entity of which he is a director and shareholder. The company disclosed that the sale represents less than 15% of his total holdings, that he retains 32,097,917 shares indirectly, and that he has no plans for further share sales in the medium term. 

Genesis shares are up 130% since the beginning of August 2025, and the FY26 result delivered EBITDA of $952.4 million, more than double the $454.1 million recorded in FY25. The company declared a maiden fully franked dividend of 5.0 cents per share, with a record date of 10 September.